Epidemiology of Lyme disease in low-incidence states

Ticks and Tick-borne Diseases

Volumn 6, Issue 6, 2015, Pages 721-723

  Forrester, Joseph D ^a,b   Brett, Meghan ^a,b   Matthias, James ^c   Stanek, Danielle ^c   Springs, Chasisity Brown ^d   Marsden Haug, Nicola ^e   Oltean, Hanna ^e,f   Baker, JoDee Summers ^g   Kugeler, Kiersten J ^b   Mead, Paul S ^b   Hinckley, Alison ^b  

^a Epidemic Intelligence Service Program   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^c FLORIDA DEPARTMENT OF HEALTH   (United States)

^d SOUTH CAROLINA DEPARTMENT OF HEALTH AND ENVIRONMENTAL CONTROL   (United States)

^e WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^g UTAH DEPARTMENT OF HEALTH   (United States)

Author keywords

Borrelia burgdorferi; Lyme disease; Misdiagnosis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DIAGNOSTIC ERROR; DISEASE SURVEILLANCE; ENZYME IMMUNOASSAY; EXPOSURE; FEMALE; HUMAN; INCIDENCE; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; UNITED STATES; ADOLESCENT; ENDEMIC DISEASE; INFANT; MIDDLE AGED; PRESCHOOL CHILD; TRAVEL; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HUMANS; INCIDENCE; INFANT; LYME DISEASE; MALE; MIDDLE AGED; TRAVEL; UNITED STATES; YOUNG ADULT;

EID: 84942366010     PISSN: 1877959X     EISSN: 18779603     Source Type: Journal    
DOI: 10.1016/j.ttbdis.2015.06.005     Document Type: Article

References (15)

1. Bacon R.M., Kugeler K.J., Mead P.S. Surveillance for Lyme disease - United States, 1992-2006. MMWR Surveill. Summ. 2008, 57(October (10)):1-9.
2. Brett M.E., Hinckley A.F., Zielinski-Gutierrez E.C., Mead P.S. U.S. healthcare providers' experience with Lyme and other tick-borne diseases. Ticks Tick Borne Dis. 2014, 5:404-408.
3. CDC Notice to readers: caution regarding testing for Lyme disease. MMWR Morb. Mortal. Wkly. 2005, 54:125.
4. CDC Notice to readers: final 2012 reports of nationally notifiable infectious diseases. MMWR Morb. Mortal. Wkly. 2013, 62:669-682.
5. Centers for Disease Control and Prevention Data and Statistics 2015, Available at: http://www.cdc.gov/lyme/stats/index.html. (accessed 02.02.15).
6. Ettestad P.J., Campbell G.L., Welbel S.F., et al. Biliary complications in the treatment of unsubstantiated Lyme disease. J. Infect. Dis. 1995, 171:356-361.
7. Hinckley A.F., Connally N.P., Meek J.I., et al. Lyme disease testing by large commercial laboratories in the United States. Clin. Infect. Dis. 2014, 59:676-681.
8. Masters E.J., Grigery C.N., Masters R.W. STARI, or Masters disease: lone star tick-vectored Lyme-like illness. Infect. Dis. Clin. N. Am. 2008, 22:361-376.
9. Nelson C., Elmendorf S., Mead P. Neoplasms Misdiagnosed as "Chronic Lyme Disease". JAMA Intern. Med. 2015, 175:132-133.
10. Patel R., Grogg K.L., Edwards W.D., Wright A.J., Schwenk N.M. Death from inappropriate therapy for Lyme disease. Clin. Infect. Dis. 2000, 31:1107-1109.
11. Reid M.C., Schoen R.T., Evans J., Rosenberg J.C., Horwitz R.I. The Consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann. Intern. Med. 1998, 128:354-362.
12. Sigal L.H. The Lyme disease controversy. Arch. Intern. Med. 1996, 156:1493-1500.
13. Tugwell P., Dennis D.T., Weinstein A., et al. Laboratory evaluation in the diagnosis of Lyme disease. Ann. Intern. Med. 1997, 127:1109-1123.
14. Wormser G.P., Masters E., Nowakski J., et al. Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin. Infect. Dis. 2005, 41(7):958-965.
15. Wormser G.P., Dattwyler R.J., Shapiro E.D., et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 43:1089-1134.